Sakar Healthcare cash flow

·UnclassifiedChart ›

Latest FY26

Cash from operations: ₹49.3cr+38.3% on FY25
Capital spending: ₹0.0cr−100.0% on FY25
Free cash flow: ₹49.3cr+1,382.4% on FY25
Cash from financing: −₹21.0cr−₹3.5 cr in FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Sep 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Changes in working capital
Adjustments to reconcile profit — non-cash items						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	—	23.6	20.9	18.1	15.0
	—	7.4	7.9	6.6	5.5
	—	0.0	0.0	0.1	0.0
	—	−0.1	−0.1	0.0	0.0
	—	0.0	0.3	−0.1	−0.2
	—	0.0	0.0	0.0	−0.1
	—	−26.4	−15.9	−12.3	−1.2
	—	−19.4	−9.8	1.1	−7.9
	—	−9.2	0.0	0.3	0.5
	—	4.7	0.0	0.0	0.0
	—	−6.0	8.4	−7.6	−0.4
	—	0.0	1.6	0.0	0.0
	—	30.5	−6.4	1.4	−4.4
	—	3.8	0.0	0.9	8.5
	—	2.6	7.5	0.0	0.0
	—	2.2	2.9	2.6	5.3
	—	0.0	0.0	0.7	0.3
	—	0.0	−0.8	0.0	0.0
Cash from operating activities
	59.6	39.8	21.5	15.9	16.9
	—	13.5	16.5	11.7	20.7
	—	53.3	38.0	27.6	37.6
	—	4.0	2.4	3.2	4.3
	—	49.3	35.6	24.5	33.3
Cash from investing activities
	—	0.0	32.3	59.6	82.2
	—	−28.4	0.0	0.0	0.0
	—	0.0	0.0	3.1	3.8
	—	0.0	0.0	4.9	4.0
	—	−28.4	−32.3	−51.5	−74.4
Cash from financing activities
	—	8.6	7.7	72.6	33.4
	—	0.0	−1.9	4.8	0.0
	—	0.0	0.0	0.0	98.2
	—	22.2	1.4	43.3	85.0
	—	7.3	7.8	6.6	5.4
	—	−0.1	−0.1	−0.1	−0.1
	—	−21.0	−3.5	27.4	41.1
	—	−0.0	−0.2	0.4	0.1
	—	−0.0	−0.2	0.4	0.1
	—	—	—	0.5	0.1
Reference items
	90.4	68.9	49.7	38.4	33.1
	30.0%	27.4%	28.0%	25.0%	24.9%
	49.3	49.3	3.3	−35.1	−48.9
	—	22.3	1.6	−84.1	—
	₹22.14	₹22.14	₹1.49	−₹15.77	−₹21.96
	42.75×	—	—	—	—
	—	1.62×	2.03×	2.10×	2.61×
	—	4.0	2.4	3.2	4.3
	—	7.3	7.8	6.6	5.4

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

SAKAR₹946.50

Sakar Healthcare Limited

· Unclassified

₹ CrorePeersMACPOWER SERVOTECH KAPSTON THEJOBETAMcap ₹2,106 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation	15.0	18.1	20.9	23.6	—
+ Finance Costs	5.5	6.6	7.9	7.4	—
+ Share-based Payments	0.0	0.1	0.0	0.0	—
+ Other Non-cash Items	0.0	0.0	-0.1	-0.1	—
+ Other — Cash Effects are Investing / Financing	-0.2	-0.1	0.3	0.0	—
+ Other Reconciling Items	-0.1	0.0	0.0	0.0	—
Changes in Working Capital
+ Inventories	-1.2	-12.3	-15.9	-26.4	—
+ Trade Receivables — Current	-7.9	1.1	-9.8	-19.4	—
+ Other Financial Assets — Current	0.5	0.3	0.0	-9.2	—
+ Other Financial Assets — Non-current	0.0	0.0	0.0	4.7	—
+ Other Current Assets	-0.4	-7.6	8.4	-6.0	—
+ Other Non-current Assets	0.0	0.0	1.6	0.0	—
+ Trade Payables — Current	-4.4	1.4	-6.4	30.5	—
+ Other Financial Liabilities — Current	8.5	0.9	0.0	3.8	—
+ Other Financial Liabilities — Non-current	0.0	0.0	7.5	2.6	—
+ Other Current Liabilities	5.3	2.6	2.9	2.2	—
+ Provisions — Current	0.3	0.7	0.0	0.0	—
+ Provisions — Non-current	0.0	0.0	-0.8	0.0	—
Cash from Operating Activities
Profit Before Tax (per I/S)	16.9	15.9	21.5	39.8	59.6
+ Total Adjustments (incl. Working Capital)	20.7	11.7	16.5	13.5	—
Cash from Operations (pre-tax)	37.6	27.6	38.0	53.3	—
+ Income Taxes Paid	4.3	3.2	2.4	4.0	—
Cash from Operating Activities	33.3	24.5	35.6	49.3	—
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)	82.2	59.6	32.3	0.0	—
+ Disp of Fixed Assets	0.0	0.0	0.0	-28.4	—
+ Disp of Investment Property	3.8	3.1	0.0	0.0	—
+ Other Inflows / (Outflows) — Investing	4.0	4.9	0.0	0.0	—
Cash from Investing Activities	-74.4	-51.5	-32.3	-28.4	—
Cash from Financing Activities
+ Proceeds from Issue of Shares	33.4	72.6	7.7	8.6	—
+ Proceeds from Other Equity Instruments	0.0	4.8	-1.9	0.0	—
+ Proceeds from Borrowings	98.2	0.0	0.0	0.0	—
+ Repayment of Borrowings	85.0	43.3	1.4	22.2	—
+ Interest Paid	5.4	6.6	7.8	7.3	—
+ Other Inflows / (Outflows) — Financing	-0.1	-0.1	-0.1	-0.1	—
Cash from Financing Activities	41.1	27.4	-3.5	-21.0	—
Net Changes in Cash (pre-FX)	0.1	0.4	-0.2	-0.0	—
Net Changes in Cash	0.1	0.4	-0.2	-0.0	—
Closing Cash	0.1	0.5	—	—	—
Reference Items
EBITDA	33.1	38.4	49.7	68.9	90.4
EBITDA Margin %	24.85	25.02	27.98	27.37	29.96
Free Cash Flow (CFO − Capex)	-48.9	-35.1	3.3	49.3	49.3
Free Cash Flow to Equity	—	-84.1	1.6	22.3	—
Free Cash Flow per Basic Share	-21.96	-15.77	1.49	22.14	22.14
Price to Free Cash Flow	—	—	—	—	42.75
Cash Flow to Net Income	2.61	2.10	2.03	1.62	—
Cash Paid for Taxes	4.3	3.2	2.4	4.0	—
Cash Paid for Interest	5.4	6.6	7.8	7.3	—

As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.